Acetylsalicylic acid from A to Z: the alphabet of usage in cardiology
Oganesova L.G.

Pirogov Russian National Research Medical University, Moscow

The paper describes, in schematic form, results of the most important trials of acetylsalicylic acid (ASA), recommendations for 
ASA appointment in main categories of patients. Thus, HOT study showed the greatest effect of ASA in the group of patients with 
AH and high and very high risk of CVD. The largest meta-analysis Antithrombotic Trialists’ Collaboration showed that previous 
ASA intake leads to 2 times increase of survival rate in patients with stroke and transient ischemic attack in anamnesis; it proved 
the efficacy of ASA in patients with both acute myocardial infarction (MI), and with a history of MI as well as the importance of 
ASA intake as first-line drug in patients with stable and unstable angina pectoris. In addition, the results of studies in patients 
with diabetes mellitusб atrial fibrillation and the elderly, most common in cardiologists practice. Various forms of ASA (enterik 
and buffer) are observed, as well as their advantages and disadvantages, according to research data.
Key words: acetylsalicylic acid, cardiovascular complications, risk, cardiology, Sanovasc.
For citation: Oganesova L.G. Acetylsalicylic acid from A to Z: the alphabet of usage in cardiology // RMJ. 2018. № 1(II). P. 104–109.